S Sreelekshmi, Shastry Shamee, B Poornima Baliga
Department of Immunohematology and Blood Transfusion, Kasturba Medical College, Manipal, India.
Acta Clin Belg. 2021 Oct;76(5):346-350. doi: 10.1080/17843286.2020.1735115. Epub 2020 Feb 28.
: Variation in the reactivity on Rh D typing may pose challenges in interpretation and ambiguity in further patient management.: A prospective study was conducted in the department of transfusion medicine for a period of 18 months. Blood grouping was performed by fully automated equipment employing column agglutination technique. All the samples with Rh D negative or discrepant reactions were subjected to weak D testing by the antihuman globulin testing method. Samples that tested positive were categorized as serological weak D type or Variant D and were further phenotyped with Partial D typing set with 6 monoclonal anti D antisera.: A total of 82,824 samples were tested for Rh D type during the study period. Of the study population, 65.7% were males. On Rh D type majority were Rh D positive (93%), 6.9% were negative, and the result was discrepant in 0.1% (70) samples. The overall prevalence of variant D was 1.28% (75) of the Rh D negative population and 0.09% of the total study population. The detection rate of variant D phenotype was significantly higher by the Column agglutination technique. Upon testing with Partial D kit, the partial D variant in the majority reacted wil all the 6 antisera and hence we could not rule out DIII(60%), in rest it was inconclusive. In 43% of subjects with Rh D discrepancy 'C' antigen was found in a homozygous state.: The introduction of partial D typing kit alone may not help in the absolute characterization of variant D. Extended serological testing and selective integration of molecular testing is the need of the hour.
Rh D血型鉴定反应性的差异可能在结果解读方面带来挑战,并在后续患者管理中造成模糊性。在输血医学科进行了一项为期18个月的前瞻性研究。采用柱凝集技术的全自动设备进行血型鉴定。所有Rh D阴性或反应不一致的样本均采用抗人球蛋白检测法进行弱D检测。检测呈阳性的样本被归类为血清学弱D型或变异D型,并进一步用含有6种单克隆抗D抗血清的部分D分型试剂盒进行表型分析。在研究期间,共检测了82,824份样本的Rh D血型。在研究人群中,65.7%为男性。在Rh D血型方面,大多数为Rh D阳性(93%),6.9%为阴性,0.1%(70份)样本结果不一致。变异D的总体患病率在Rh D阴性人群中为1.28%(75例),在整个研究人群中为0.09%。柱凝集技术检测变异D表型的检出率显著更高。使用部分D试剂盒检测时,大多数部分D变异体与所有6种抗血清均发生反应,因此我们无法排除DIII(60%),其余情况则无法得出结论。在43%的Rh D血型不一致的受试者中,发现“C”抗原呈纯合状态。仅引入部分D分型试剂盒可能无助于对变异D进行绝对特征描述。目前需要进行扩展的血清学检测并选择性整合分子检测。